Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi)
Clinical trials sponsored by Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi), explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Heart attack prevention hope for rare cholesterol disorder Results expected Dec 2026 (estimated)
- New hope for rare cholesterol disease: can evinacumab shrink dangerous plaque? Results expected Sep 2027 (estimated)